BPTH Bio-Path Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: BPTH

Price (delayed)

$0.5432

Market cap

$6.71M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.04

Enterprise value

$4.5M

Bio-Path is a biotechnology company developing DNAbilize®, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous infusion. Bio-Path's lead ...

Highlights
Bio-Path Holdings's debt has decreased by 43% YoY and by 16% QoQ
Bio-Path Holdings's EPS has increased by 8% from the previous quarter but it has decreased by 3.6% YoY
BPTH's equity has dropped by 84% year-on-year and by 50% since the previous quarter
The quick ratio has plunged by 72% YoY and by 29% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.biopathholdings.com
Peers: BAX SGEN BMY

Key stats

What are the main financial stats of BPTH
Market
Shares outstanding
12.35M
Market cap
$6.71M
Enterprise value
$4.5M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.47
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$16.67M
EBITDA
-$16.49M
Free cash flow
-$14.72M
Per share
EPS
-$2.04
Free cash flow per share
-$1.46
Book value per share
$0.22
Revenue per share
$0
TBVPS
$0.5
Balance sheet
Total assets
$5.02M
Total liabilities
$2.5M
Debt
$141,000
Equity
$2.53M
Working capital
$3.45M
Liquidity
Debt to equity
0.06
Current ratio
3.54
Quick ratio
1.73
Net debt/EBITDA
0.13
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-172.7%
Return on equity
-216.2%
Return on invested capital
-663.2%
Return on capital employed
-455%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BPTH stock price

How has the Bio-Path Holdings stock price performed over time
Intraday
-0.77%
1 week
0.59%
1 month
-12.53%
1 year
-64.5%
YTD
-64.03%
QTD
46.81%

Financial performance

How have Bio-Path Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$16.8M
Net income
-$16.67M
Gross margin
N/A
Net margin
N/A
The operating income is down by 20% year-on-year
BPTH's net income is down by 19% year-on-year

Growth

What is Bio-Path Holdings's growth rate over time

Valuation

What is Bio-Path Holdings stock price valuation
P/E
N/A
P/B
2.47
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Bio-Path Holdings's EPS has increased by 8% from the previous quarter but it has decreased by 3.6% YoY
BPTH's equity has dropped by 84% year-on-year and by 50% since the previous quarter
The stock's price to book (P/B) is 65% more than its 5-year quarterly average of 1.5 and 54% more than its last 4 quarters average of 1.6

Efficiency

How efficient is Bio-Path Holdings business performance
BPTH's return on assets has dropped by 178% year-on-year and by 32% since the previous quarter
The return on equity has declined by 41% since the previous quarter
BPTH's ROIC is down by 12% QoQ and by 12% YoY

Dividends

What is BPTH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BPTH.

Financial health

How did Bio-Path Holdings financials performed over time
The total assets is 101% more than the total liabilities
The total assets has plunged by 73% YoY and by 23% from the previous quarter
The quick ratio has plunged by 72% YoY and by 29% from the previous quarter
Bio-Path Holdings's debt is 94% lower than its equity
The company's debt to equity has surged by 200% YoY and by 100% QoQ
BPTH's equity has dropped by 84% year-on-year and by 50% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.